Whoop
After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
· Reported by STAT
After warning letter, Whoop and FDA in discussions about controversial blood pressure feature STAT
More Whoop this month
- Whoop CEO Exposes the Real Reason Behind Tech Layoffs: AI Is a 'Scapegoat' for Executives
- WHOOP Researchers Contribute to New Peer-Reviewed Review on Travel, Recovery, and Performance
- WHOOP Body: Future of Wearable Technology
- After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
- WHOOP launches clinician video visits, EHR integration with HealthEx
- WHOOP’s $10B Deal Begs Question, Can The Brand Cross Over Into Health?